Understanding Cardiometabolic Risk
It has been well documented in the past several decades that having diabetes significantly increases the risk for cardiovascular disease. In fact the risk factor in cardiovascular events among diabetics is sometimes placed in the same categories as patients with a previous Myocardial Infarction. This long standing relationship has led to an understanding of the complex mechanics between these two disease states, which is now best described as Cardiometabolic Disease.
Metabolic Cardiology is essentially looking at the biochemical interventions we use to directly improve energy metabolism in heart cells by supporting the cellular metabolic functions such as ATP energy production with cellular nutrients like D-Ribose, Coenzyme Q10, L-Carnitine and Magnesium to name a few. Also, with lifestyle changes of diet, exercise and sleep along with numerous advanced tests of common and emerging fasting blood markers will allow Dr. Ginkel to predict which patients may be at an increased risk for diabetes or cardiovascular events allowing for more comprehensive strategies of prevention with greater health benefits.
The ideal Cardiometabolic diet for reducing Cardiometabolic risk would include;
- Improving insulin sensitivity
- Reducing inflammation
- Promoting weight loss
- Reducing fat mass or adiposity
- Physical activity/exercise
- Stress reduction
- Adequate Quality Sleep
- Reducing advanced glycation endproducts (AGEs)
- Improving omega-3 to omega-6 fatty acid ratios
- Easy to implement
All at risk patients should first be assessed within the Cardiometabolic risk factors to determine what relationships may be connecting the manifested biomarkers. By first assessing the role of insulin resistance, and applying a global lifestyle therapies that can impact BP (blood pressure), dyslipidemia, adiposity and inflammatory markers. Once insulin resistance has been accounted for, other specific therapeutic goals can be set for other biomarkers.